AKT1 and Hyperglycemia: These findings were consistent with previous observations that pathological overexpression of TRIB3 blocked insulin-induced Akt phosphorylation, negatively regulated insulin action, and contributed to hyperglycemia and insulin resistance in liver and skeletal muscle (Du et al., 2003; Liu et al., 2010).